The Government is moving ahead with plans to amend legislation to attract drug research back to the UK. If the changes go ahead, they will remove risks of patent infringement claims when carrying out clinical and other experimental trials of new drugs, according to Withers & Rogers – one of the UK’s leading firms of patent and trade mark attorneys.
23 May, 2014